T-Cell Acute Lymphoblastic Leukemia

The purpose of this study is to determine the safety and effectiveness of an experimental form of therapy, known as BEAM-201.

The purpose of this study is to determine the safety and tolerability of an experimental form of therapy, known as WU-CART-007 (“study drug”). 

The Teachey Lab studies perturbations in leukemic cell signal transduction pathways with the aim of identifying targeted cancer inhibitors and immunotherapies that can treat children with high-risk leukemias and autoimmune lymphoproliferative syndrome.